JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. (Q34218711)

31 July 2017

title

JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. (English)

1 reference

31 July 2017

1 reference

ChEBI release 2020-05-28

15

Morito Monden

1 reference

31 July 2017

11

Koji Umeshita

1 reference

31 July 2017

10

Keizo Dono

1 reference

31 July 2017

3

Shoji Nakamori

1 reference

31 July 2017

12

Mitsugu Sekimoto

1 reference

31 July 2017

Bazarragchaa Damdinsuren

9

object named as

Bazarragchaa Damdinsuren

1 reference

31 July 2017

Hirofumi Yamamoto

1

1 reference

31 July 2017

Motoi Kondo

2

1 reference

31 July 2017

Hiroaki Nagano

4

1 reference

31 July 2017

Ken-Ichi Wakasa

5

1 reference

31 July 2017

Yurika Sugita

6

1 reference

31 July 2017

Jin Chang-De

7

1 reference

31 July 2017

Shogo Kobayashi

8

1 reference

31 July 2017

Masato Sakon

13

1 reference

31 July 2017

Nariaki Matsuura

14

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

125

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

556-571

1 reference

31 July 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Human cyclooxygenase-2 cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Profile of JTE-522 as a human cyclooxygenase-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Inhibition by piroxicam of oxidative DNA damage, liver cirrhosis and development of enzyme-altered nodules caused by a choline-deficient, L-amino acid-defined diet in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Prevention by inhibitors of arachidonic acid cascade of liver carcinogenesis, cirrhosis and oxidative DNA damage caused by a choline-deficient, L-amino acid-defined diet in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Increased cell proliferation of azoxymethane-induced aberrant crypt foci of rat colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Prevention of cross-contamination during sampling procedure in molecular detection for cancer micrometastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Single GST-P positive liver cells--putative initiated hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Differential expression of hepatocyte growth factor, transforming growth factor-alpha and transforming growth factor-beta 1 messenger RNAs in two experimental models of liver cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Meloxicam inhibits the growth of colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Choline deficiency causes increased localization of transforming growth factor-beta1 signaling proteins and apoptosis in the rat liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Induction of cyclooxygenase-2 in Ras-transformed human mammary epithelial cells undergoing apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

Natural history of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900904-1

10.1016/S0016-5085(03)00904-1

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference